BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Prognosis
20 results:

  • 1. Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate cancer.
    Saylor PJ; Otani K; Balza R; Ukleja J; Pleskow H; Fisher R; Kusaka E; Otani YS; Badusi PO; Smith MR; Meneely E; Olivier K; Lowe AC; Toner M; Maheswaran S; Haber DA; Yeap BY; Lee RJ; Miyamoto DT
    JCO Precis Oncol; 2024 Feb; 8():e2300230. PubMed ID: 38354328
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. METTL3-induced lncRNA GBAP1 promotes hepatocellular carcinoma progression by activating BMP/SMAD pathway.
    Liu R; Yin G; Tuo H; Guo Y; Zhu Y; Zhang L; Yang W; Liu Q; Wang Y
    Biol Direct; 2023 Sep; 18(1):53. PubMed ID: 37658413
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. bone metastatic cancer of unknown primary at initial presentation.
    Matsuoka M; Onodera T; Yokota I; Iwasaki K; Suzuki Y; Masanari H; Kondo E; Iwasaki N
    Clin Transl Oncol; 2024 Feb; 26(2):461-467. PubMed ID: 37395989
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical risk factors for severity and prognosis of antiresorptive agent-related osteonecrosis of the jaw: a retrospective observational study.
    Nashi M; Hirai T; Iwamoto T; Takenobu T
    J Bone Miner Metab; 2022 Nov; 40(6):1014-1020. PubMed ID: 36166107
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Application of Endoprosthetic Replacement in Old Patients with Isolated Proximal Femoral bone Metastases.
    Liu P; Wang Z; Zhang S; Ding G; Tan K; Zhou J
    Ann Surg Oncol; 2022 Dec; 29(13):8623-8630. PubMed ID: 35606471
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. bone morphogenetic protein induces bone invasion of melanoma by epithelial-mesenchymal transition via the Smad1/5 signaling pathway.
    Gao J; Muroya R; Huang F; Nagata K; Shin M; Nagano R; Tajiri Y; Fujii S; Yamaza T; Aoki K; Tamura Y; Inoue M; Chishaki S; Kukita T; Okabe K; Matsuda M; Mori Y; Kiyoshima T; Jimi E
    Lab Invest; 2021 Nov; 101(11):1475-1483. PubMed ID: 34504305
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real-life data.
    Gürbüz M; Doğan İ; Akkuş E; Ermiş H; Utkan G; Vatansever S; Taş F
    Dermatol Ther; 2021 Nov; 34(6):e15122. PubMed ID: 34478210
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Risk Factors, Prognostic Factors, and Nomograms for Distant Metastasis in Patients With Newly Diagnosed Osteosarcoma: A Population-Based Study.
    Chen B; Zeng Y; Liu B; Lu G; Xiang Z; Chen J; Yu Y; Zuo Z; Lin Y; Ma J
    Front Endocrinol (Lausanne); 2021; 12():672024. PubMed ID: 34393996
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A new glioma grading model based on histopathology and bone Morphogenetic Protein 2 mRNA expression.
    Zhou K; Zhao Z; Li S; Liu Y; Li G; Jiang T
    Sci Rep; 2020 Oct; 10(1):18420. PubMed ID: 33116227
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles.
    Yan HHN; Siu HC; Ho SL; Yue SSK; Gao Y; Tsui WY; Chan D; Chan AS; Wong JWH; Man AHY; Lee BCH; Chan ASY; Chan AKW; Hui HS; Cheung AKL; Law WL; Lo OSH; Yuen ST; Clevers H; Leung SY
    Gut; 2020 Dec; 69(12):2165-2179. PubMed ID: 32217638
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Aplastic anemia associated with Crohn's disease: a tertiary center retrospective study.
    Su S; Liu Z; Wang F; Zhang Y; Chu Y; Jiang M; Xu B; Wu N; Lin J; Xue X; Shi Y; Yang S; Wu K; Liang J
    Ann Hematol; 2019 Sep; 98(9):2053-2061. PubMed ID: 31256218
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinicopathologic features of anaplastic myxopapillary ependymomas.
    Lee JC; Sharifai N; Dahiya S; Kleinschmidt-DeMasters BK; Rosenblum MK; Reis GF; Samuel D; Siongco AM; Santi M; Storm PB; Ferris SP; Bollen AW; Pekmezci M; Solomon DA; Tihan T; Perry A
    Brain Pathol; 2019 Jan; 29(1):75-84. PubMed ID: 30417460
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Harnessing the BMP signaling pathway to control the formation of cancer stem cells by effects on epithelial-to-mesenchymal transition.
    Bosukonda A; Carlson WD
    Biochem Soc Trans; 2017 Feb; 45(1):223-228. PubMed ID: 28202676
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.
    Yamada Y; Katsoulakis E; Laufer I; Lovelock M; Barzilai O; McLaughlin LA; Zhang Z; Schmitt AM; Higginson DS; Lis E; Zelefsky MJ; Mechalakos J; Bilsky MH
    Neurosurg Focus; 2017 Jan; 42(1):E6. PubMed ID: 28041329
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Serum alkaline phosphatase predicts survival outcomes in patients with skeletal metastatic nasopharyngeal carcinoma.
    Jin Y; Yuan MQ; Chen JQ; Zhang YP
    Clinics (Sao Paulo); 2015 Apr; 70(4):264-72. PubMed ID: 26017793
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Loss of SMAD4 alters BMP signaling to promote colorectal cancer cell metastasis via activation of Rho and ROCK.
    Voorneveld PW; Kodach LL; Jacobs RJ; Liv N; Zonnevylle AC; Hoogenboom JP; Biemond I; Verspaget HW; Hommes DW; de Rooij K; van Noesel CJ; Morreau H; van Wezel T; Offerhaus GJ; van den Brink GR; Peppelenbosch MP; Ten Dijke P; Hardwick JC
    Gastroenterology; 2014 Jul; 147(1):196-208.e13. PubMed ID: 24704720
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Modulation of bone morphogenic protein signaling in T-cells for cancer immunotherapy.
    Kuczma M; Kurczewska A; Kraj P
    J Immunotoxicol; 2014 Oct; 11(4):319-27. PubMed ID: 24350726
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
    Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
    Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications.
    Yoshimoto M; Ludkovski O; DeGrace D; Williams JL; Evans A; Sircar K; Bismar TA; Nuin P; Squire JA
    Genes Chromosomes Cancer; 2012 Feb; 51(2):149-60. PubMed ID: 22045666
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Serial prostatic histology. A valid marker of response to hormone treatment.
    Bishop MC; Ansell ID; Taylor MC; Thomas AL
    Br J Urol; 1985 Aug; 57(4):453-7. PubMed ID: 3896369
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.